Krystal Biotech Announces Early Evidence of Monotherapy Activity in Heavily Pre-Treated Patients with Advanced Non-Small Cell Lung Cancer
Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27% ORR and 73% DCR in monotherapy trialMonotherapy activity with ...
Lung cancer as a nonsmoker younger than 40? Yes, as Central Texas woman found out.
Woman from Central Texas thought she had allergies. Then she learned she had lung cancer, although she never smoked.
Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
In 33 heavily pretreated NSCLC EGFR wild-type (EGFRwt) patients the combination of AFM24 and atezolizumab shows an overall ...
News Medical on MSN5d
Multi-omic profiling sheds light on chemo-immunotherapy resistance in lung cancer
The study characterizes the lung cancer tumor microenvironment, linking cellular compositions to immunotherapy resistance and ...
Managed Healthcare Executive5d
Two New FDA Approvals in Lung Cancer
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
News Medical on MSN6d
PROSPECT-Lung trial aims to improve treatment for patients with resectable non-small cell lung cancer
The highly anticipated PROSPECT-Lung trial has officially opened, marking a significant step forward in the quest to improve treatment strategies for patients with resectable non-small cell lung ...
Scientists develop scans that light up aggressive cancer tumors for better treatment
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that ...
The American Journal of Managed Care5d
Next-Gen Strategies for Resistance in EGFR-Mutated Lung Cancer
Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...
Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several ...
Russia’s cancer vaccine is ready. Here’s why it matters
Russia has reportedly developed a vaccine against cancer that it will launch early next year. The jab, which will be free of cost, will treat patients instead of preventing the disease in the general ...
US FDA declines to approve injection form of J&J's lung cancer drug
The FDA's so-called complete response letter was related to observations as part of a standard pre-approval inspection at a ...